Event Abstract

Back to Event

Caprylic Acid in the purification of horse tetanus IgG immunoglobulin

Antonio M. Cruz1, 2*, Otero A. Oscar3, Dailin C. Dailin4 and Pérez M. Oliver5
  • 1 Centro de Inmunología y Biopreparados de Holguín. LABIOFAM., Research and Development, Cuba
  • 2 Universidad de Ciencias Médicas de Holguín, Research, Cuba
  • 3 Instituto Finlay, Cuba
  • 4 Centro de Inmunología y Biopreparados de Holguín, Resaerch and Development, Cuba
  • 5 Instituto de Ciencias Médicas Girón. Huniversidad de La Habana, Cuba

Purified horse anti tetanus toxin immunoglobulins with high antibody concentration and biological activity, are used as heterologous sera and standard serum for corresponding vaccine. However, the selection of precipitating agents for the purification of them is a problem in terms of purity, yield and economy, which still remains to be solved. In this study, a procedure to fractionation horse plasma anti tetanus toxin by Caprylic acid precipitation is described. A solution of acetic acid/sodium acetate was added to the samples to achieve different ionic strengths, 0.05-0.4 moles/L, and caprylic acid was added to each volume to reach final concentrations from 1 to 7% (v / v), with vigorous stirring for 60 min. Non-immunoglobulin proteins precipitated under these conditions, while immunoglobulins remained in the supernatant, which was then diafiltered to remove caprylic acid and concentrate inmunoglobulins. This methodology was compared to that based on ammonium sulfate fractionation. The best results were given when caprylic acid was added to plasma, until a final caprylic acid concentration of 3% was reached, at ionic strength 0.2 moles/L and pH adjusted to 4.5. The IgG recovery was 91-95% by using the caprylic acid method. It was achieved a protein concentration of 27.1-29.3 mg/mL and an albumin/immunoglobulins ratio of 0.019-0.021. The purity was 91- 95% and the anti-tetanus toxin activity recovery of 93-96%.

References

Morais VM, Massaldi H. Snake antivenoms: adverse reactions and production technology. J Venom Anim Toxins Trop Dis 2009;15(1):2-18.
Wagner KS, Stickings P, White JM, Neal S, Crowcroft NS, Sesardic D, et al. A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use. Vaccine 2010;28:14-20.
Raweerith R, Ratanabanangkoon K. Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography. J Immunol Meth 2003;282:63-72.
Rojas G, Jiménez JM, Gutiérrez JM. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production. Toxicon 1994;32:351-63.
Morais V, Massald H. A model mechanism for protein precipitation by caprylic ac id: Application to plasma puri fi cation. Biotechnol Appl Biochem 2012;59(1):50-4.
Miranda AR, Sánchez R, Góngora W, Mulet O. Obtención de sueros hiperinmunes de origen equino antitoxina tetánica, utilizando adyuvante oleoso. COCMED 2006;10(3). Disponible en: http://www.cocmed.sld.cu/no103/ n103ori8.htm.
Gutiérrez JM, Rojas E, Quesada L, León G, Núñez J, Laing GD, et al. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa. Trans R Soc Trop Med Hyg 2005;99:468-75.

Keywords: antitetanus toxin, caprylic acid., protein presipitation, Horse immunoglobulins, Ammonium sulfate fractionation

Conference: IMMUNOCOLOMBIA2015 - 11th Congress of the Latin American Association of Immunology - 10o. Congreso de la Asociación Colombiana de Alergia, Asma e Inmunología, Medellin, Colombia, 13 Oct - 16 Oct, 2015.

Presentation Type: Poster Presentation

Topic: Veterinary and Comparative Immunology

Citation: Cruz AM, Oscar OA, Dailin DC and Oliver PM (2015). Caprylic Acid in the purification of horse tetanus IgG immunoglobulin. Front. Immunol. Conference Abstract: IMMUNOCOLOMBIA2015 - 11th Congress of the Latin American Association of Immunology - 10o. Congreso de la Asociación Colombiana de Alergia, Asma e Inmunología. doi: 10.3389/conf.fimmu.2015.05.00241

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 12 May 2015; Published Online: 14 Sep 2015.

* Correspondence: PhD. Antonio M Cruz, Centro de Inmunología y Biopreparados de Holguín. LABIOFAM., Research and Development, Holguín, Holguín, Cuba, antonio@cibho.hlg.sld.cu